Hypothermia facilitates transthoracic defibrillation  by Rhee, Benjamin J et al.
350A ABSTRACTS - Myocardial Ischemia and Infarction 
Conclusions: The TIMI risk index provides excellent prediction of long-term mortality 
after hospitalization with primary UA. independent of other variables. Our findmgs extend 
the utility of this risk index to unselected patients with UA and to long-term risk prediction. 
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1072-l 05 Impact of Diabetes Mellitus on Long-Term Outcome 
After Non-ST-Elevation Acute Coronary Syndromes 
Treated With Very Early Revascularization 
ChristIan Mueller, Franz-Josef Neumann, Helmut Roskamm, Andre P. Perruchoud, 
Heinz J. Buettner, University Hospital, Easel, Switzerland, Hew-Zentrum, Bad 
Krozingen, Germany 
Background: Limited informatlon is available regarding the outcome of diabetic patients 
treated with very early revascularizatlon for no-ST-elevation acute coronary syndromes 
(NSTACS). Methods: We conducted a prospective cohort study in 270 diabetics and 
1163 nondiabetics with NSTACS undergoing coronary angiography and subsequent 
revascularizatlon within 24 hours of admission. The primary endpoint was all-cause mor- 
tality and recorded for a mean of 20 months. Results: There were important differences 
in baselme characteristics. Most importantly, diabetics were older, and more often had 
previous myocardial Infarction and three vessel disease as compared with nondiabetics. 
In addition, the NSTACS was more severe in diabetics, as cardiopulmonary resuscita- 
tion, ST-segment depression and raised Troponin T occurred more ofien in diabetics. 
Consequently, in-hospital (4.1% versus 1.3%, hazard ratio 3.47: 95% Cl, 1.57 to 7.64; 
p=O.OOZ) and long-term mortality (9.7% versus 4.9%, hazard ratio 2.1 I; 95% Cl, 1.33 to 
3.36; p=O.OOZ) were significantly higher In diabetics. However, after adjustment for these 
differences in baseline characteristics, diabetes was no longer an independent predictor 
of long-term morialtty (hazard ratio 1.43; 95% Cl, 0.74 to 2.78; p=O.292). The prognostlc 
impact of diabetes was different in women and men. Conclusion: Diabetic patients with 
NSTACS do have a higher in-hospital and long-term mortality due to their more 
advanced CAD and more severe NSTACS. However, very early revascularizatlon seems 
to improve outcome in patients with diabetes and compensate for much of the extra risk 
factors present particular in diabetic women. 
POSTER SESSION 
1073 Advances in Transthoracic Defibrillation 
Monday, March 31, 2003, 9:00 a.m.-l 1:OO a.m. 
McCormick Place, Hall A 
Presentation Hour: 9:00 a.m.-10:OO a.m. 
1073-89 Escalating Energy Is More Effective Than Fixed Energy 
Defibrillation for Ischemically Induced Ventricular 
Fibrillation 
Emad Khaleeli, James T. Niemann, Robert G. Walker, John P. Rosborough, Harbor- 
UCLA MedIcal Center, Torrance, CA 
Background: Defibrillation, the principle challenge for out-of-hospital resuscitation, is 
best studted in clinically relevant models. Electrically induced VF in animals with charac- 
teristically low transthoracic impedance (TTI) (30.500) is readily terminated by lower 
energy (15OJ) shocks. We hypothewed that a model of ischemic VF combined with TTI 
more typical of humans would require higher energy shocks for defibrillation. Methods: 
18 anesthetized swine were randomized to fixed, low energy (15OJ) transthoracic shocks 
(Group 1, n=9) or escalating, higher energy (ZOO-300-36OJ) shocks (Group 2, n=9). 
Thirty ohms were added in series to the measured TTI (obtained during a 3OJ shock 
while in sinus rhythm) of each pig. A multielectrode-tipped catheter was positioned in the 
coronary sinus for determination of electrical field strength (V/cm) produced by each tran- 
sthoracic shock. VF was then induced by percutaneous balloon occlusion of a coronary 
artery. After 1 minute or 5 minutes of VF, countershocks with a biphasic truncated expo- 
nential waveform were administered at end-expiration using adhesive electrodes applied 
to the left and right lateral thorax. The primary endpoint was successful defibrillation with 
<3 shocks. 
Results: The mean TT was not different between the groups (Group 1,82~110; Group 
2, 84+7 0), nor was the first shock peak current (Group 1, 18.1*1.2 A; Group 2, 20.3kO.l 
A). Only one of the group 1 animals (11%) could be defibrillated with up to 3 shocks, 
each at 150 J. All Group 2 animals were successfully defibrillated. Eight of 9 group 2 ani- 
mals were defibrillated with < 2 shocks (p<O.OOl YS Groupl). The negative predictive 
value of a field strength of cl0 V/cm was 100%. 
Conclusions: In this ischemically induced VF animal model, 1. fixed, lower energy 
shocks were less effective than higher energies administered in an escalating dose pro- 
tocol. 2. the effective energy dose for defibnllation was higher than that reported in elec- 
trically induced VF models, and 3. the electric field strength required for transthoracic 
deftbrillation was greater than 10 V/cm and a value less than this was predictive of 
defibrillation failure. 
1073-90 Comparison of Weight-Based Monophasic and Fixed- 
Sequence Biphasic Defibrillation Dosing for 
Resuscitation in a Model of Pediatric Prolonged Cardiac 
Arrest 
Robert A. Berg, Ronald W. Hilwig, Fred W. Chapman, Robert G. Walker, Richard C. 
Nova, Marc D. Berg, Karl B. Kern, Gordon A. Ewy, University of Arizona, Tucson, AZ, 
Medtronic Physio-Control Corp., Redmond, WA 
Background: Standard therapy for patients under 8 years old in ventricular fibnllation 
(VF) is to shock with a weight-based defibrillation dose. Since weight-based dosing is not 
feasible for automated external defibdllators (AEDs), it is important to learn If a single 
escalating energy sequence IS effective over the weight range of children under 8. 
Methods: After 7 minutes of untreated VF, 4. 14 and 24 kg piglets (10 of each weight) 
were randomized to receive monophasic 2,4,4 J/kg therapy (M) or a biphasic sequence 
of 50, 75, 86 J (B). Resuscitation was per peds BLS protocol to 20 minutes, then peds 
ALS protocol to 27 minutes. Endpoints 4.hr survival and 24.hr survival with good neuro- 
logical outcome (cerebral performance category 1 or 2) were analyzed by Fisher’s exact 
test; energy and number of shocks were analyzed by Student‘s t-test. 
Results: Many more M than B shocks failed to defibrillate the first episode of VF (12 * 7 
vs. 2 * 3 failed shocks, p<O.OOl) resulting in higher cumulative energy for M than B (59 * 
29 vs. 24 * 24 J/kg, p=O.OOl). More B than M piglets survived to 4 hrs (1505 vs. 7/i& 
p=O.OOZ) and subsequently surwved to 24 hours with good neuro scores (14/15 vs. 5115, 
p=O.O02). Most non-survivors had refractory VF. 
Conclusions: This study showed that a smgle escalating biphasic dosing sequence con- 
sistently resuscitates piglets after prolonged VF, an important issue for pediatric AEDs. 
This therapy produced outcome superior to the recommended monophasic weight-based 
dosing over a wide weight range. 
4 kg Weight 14 kg Weight 24 kg 
Weight 
M B M B M B 
Cumulative delivered energy, J/kg, 50+ 42- 40 * 21- 88* s-4 
mean * sd 19 22 32 28 6 
# Failedshocks, 15’VFep~sode. 10 * 0.2 - 8.6 * 3.4- t8* 2 - 
mean r sd 6 0.4 7.4 5.5 2 1.4 
4.hrsurvival 315 55 315 !z l/5 55 
Good 24.hr neuro Z/5 415 315 ytj o/5 5/?j 
1073-91 Detection and Discrimination Performance of an 
Automatic External Defibrillator in Ambulatory Patients 
During Treadmill Exercise 
Thomas A. Matiioni, Sue Welch, Nabil Kansan, Wendy Miller, Don Lin, Arizona Heart 
Institute, Phoenix, AZ, Cardiac Science, Inc., Irvine, CA 
The Powerhearl CRM (Cardiac Rhythm Monitor) is the next generation automatic exter- 
nal cardioverter defibrillator (AECD) deslgned for in-hospital use. This AECD has a pro- 
grammable supraventricularlventricular tachycardia (SVTNT) discrimination algorithm 
designed to inhibit therapy delivery in the presence of SVT. This algorithm is also incor- 
porated into the Powerheart AED (Automatic External Defibrillator) designed for out of 
hospltal, first responder use. The present study was performed to assess algorithm per- 
formance in ainbulatory p&tents. 
A total of 50 participants (50 Males) in a cardiac rehabilitation program were attached to 
the AECD via externally applied adhesive electrode pads In the sternum-apex configura- 
tlon. It was programmed to dwximinate SVT from VT withln a heart rate zone of 120 to 
200 bpm in the advisory mode. Patients then walked on a conventional treadmill until lim- 
ited by symptoms. Patients exercised for 7 to 15 minutes at a speed of 3.0 to 5.0 mph at 
0 to IO degrees grade. Only 22 patients achwed peak heart rates of greater than 120 
bpm (mean peak heart rate 134 bpm). There were 4 episodes of artifact detection but no 
advice for therapy delivery in these 22 patients. There was one episode of recommended 
shock delivery at peak exercise at 7 minutes and heart rate of 106 bpm. This resulted in 
a specificity of 95.6%. In conclusion, this algorithm was very successful in rejecting arti- 
fact and discriminating SVT from VT during symptom-limited exertion and would be 
expected to perform very well In ambulatory patients. 
1073-92 Hypothermia Facilitates Transthoracic Defibrillation 
Beniamin J. Rhee, Yi Zhang, Loyd R. Davies, Richard E. Kerber, University of Iowa, Iowa 
City, IA 
Background: Induced hypothermia (H) appears a promising intenention to protect the 
heart during and after resuscitation from cardiac arrest. However, the influence of H on 
defibrillation energy requirements IS not well characterized. We studied the effect of body 
hypothermia on transthoracic defibrillation energy requirements, transthoraclc impe- 
dence (TTI) and current using a swine model. 
Methods: In 8 animals (21.4 * 1.3(SE) kg) ventricular fibrillation (VF) was induced by 
delivery of 60 Hz AC current to the right ventricular apex. After 30 seconds of VF, the nor- 
mothermic (N) swine were defibrillated (biphasic waveform) at ZOJ. 3OJ, 5OJ, and IOOJ. 
The swine were cooled to 30” C by surroundmg the head, thorax, and abdomen with ice, 
and then underwent defibrillation at the same energies. 
Results: Shock success I” terminating VF was higher during H (pcO.001, odds ratio 3.98, 
95% Cl: 1.95, 8.12), despite the fact that TTI rose from 39 f 3 (SD) ohms (N) to 42 f 3 
(SD) ohms (H) (pcO.001) and current fell from 22 d 8 (N) to 21 * 7 Amperes (H) 
(pcO.001). Post-defibrillation asystole occurred In 3 of 8 swine (N) vs. 0 of 8 (H) (pcO.05). 
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Conclwon: Moderate H facilitates transthoracic defibrillation. Since TTI rose and current 
fell during H, the improved shock success must be due to a hypothermia-induced change 
in the mechanical or electrophysiologic properties of the myccardium. 
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1073-93 Performance of an Automated External Cardioverter 
Defibrillator for In-Hospital Ventricular Malignant 
Arrhythmia 
Seroio Timerman, Andre M. Bento, Luiz F. Cardoso, Miguel A. Moretti, Nabil E. Sanadl, 
Jose A. Ramires. Heart Institute (InCor) University of Sao Paula Medical School, Sao 
Paula, Brazil 
Purpose: Ventricular fibrillation (VF) and ventricular tachycardia (VT) are the major 
underlying rhythm during in-hospital cardiac arrest. For a patient in VFNT the probability 
of successful defibrillation and subsequent suwival to hospital discharge is directly and 
negatively related to the time interval between onset of the arrhythmia and delivery of the 
first shock. The data about this interval in clinical practice is heterogeneous and ~nconclu- 
sive, however the literature estimates it to be about 60 seconds in monitored units. Con- 
tinuos ECG monitoring allows identification of such arrhythmias and alert nursmg and 
medical staff. The time delay between the arrhyihmlc event and human intervention is 
still a challenge for clinical practice. 
Methods: We reported the use of an automated external cardioverter defibrillator (AECD) 
in 45 patients considered to be at higher risk for malIgnant arrhythmia for 24 to 48 hours. 
The inclusion criteria was acute coronary syndrome, cardiogemc shock and previous epi- 
sode of sudden death or malignant ventricular arrhythmia. The exclusion cnteria was the 
use of pacemaker or an implantable cardioverier defibrillator and an R-wave amplitude 
less than 0.7mV peak to peak at themonitor. 
Results: We recorded 17 episodes of VTNF in 3 patients. The median time between the 
beginning of the arrhythmia and the first defibrillation was 33.37 s (range 21 to 65 s). The 
sensibility and specificity were 100%. The success of the defibrillation was 94.11% (16/ 
17) for the first shock and 100% (l/l) for the second shock. There was no adverse event 
during the study penod and no episodes of inappropriate therapy delivery (the detection 
was accurate in all episodes sensitivity 100%). 
Conclusion: AECD was safe and effective. It presents the possibility of providing consis- 
tently rapid identification and response to ventricular malignant arrhyihmla. 
1073-94 The Potential Impact of a Fully Automated External 
Cardioverter Defibrillator in Centrally Monitored 
Hospital Units 
Hew Cusnir, Rohit Tongia. David Kavesteen, Karthik P. Sheka, Frederick Cassera. 
Hannah Scherer, Louise Valeno, Gerald Hollander, Maimonides Medical Center. 
Brooklyn, NY 
Background: Sudden Cardiac Arrest (SCA) survival decreases by 10% for each minute 
of delay in cardioversion, wth survival rates of 96% noted when defibrillation is achieved 
within 30 seconds of collapse. This has led to increasing use of semi-automated external 
defibrillators in many out-of-hospital settings. Recently, a fully automated external cardio- 
verter-defibrillator (AECD) was approved by the FDA for in-hospital use. The AECD can 
be programmed to automatically defibrillate a life threatening ventricular arrhythmia. The 
purpose of this study was to assess the potential impact of in-hospital AECDs on the crit- 
ical time to defibrillation in monitored hospital units. 
Methods: Mock codes (n=l6) were conducted using simulated ventricular fibrillation in 
various monitored units. Observers were stationed to record the time staff responded to 
the arrhythmia, and the time to shock. These times were compared to an AECD protocol 
that automatically defibrillates at an average of 36.3 seconds from onset of arrhythmia 
(ll=l8). 
Results: Staff vs AECD response time to arrhythmia (seconds) was 76.3 f 113.7 (Cl 
19.6 132.6) vs 7.6 f 0.6 (Cl 7.3 7.9). Staff vs AECD time to shock was 169.2 * 103.1 
(Cl 117.9 - 220.4) vs 36.3 * 0.7‘(CI 37.9 - 36.6). p values are < 0.0001 for differences 
between the groups. 
Defibrillation 
Conclusion: AECDs on monitored units could significantly reduce the critical time to 
defibrillation in patients with SCA. We anticipate this would translate to improved survival 
rates, with better neurologlc outcomes. 
1073-95 Immediate Defibrillation Predicts Probability of 
Defibrillation Curve Width for External Defibrillation 
Waveforms 
Oscar H. Tovar, David E. Snyder, Janice L. Jones, VA Medical Center-Georgetown 
University, Washington, DC, Philips Medical Systems, Seattle, WA 
Background: Defibrillation is either immediate (ID) or progressive, i.e. followed by extra- 
systoles before termination, but significance of ID remains unknown. Waveforms having 
large probability of success (POS) curve width are poor for defibrillation because out- 
come is uncertain over a large shock intensity range. We tested the hypothesis that 
waveforms having primarily ID at I50 (current for 50% success) have narrow POS curve 
width. Methods: POS curves were obtained in 21 isolated rabbit hearts using monopha- 
sic damped sine (MDS), and monophasic and biphasic truncated exponential (BTE) 
waveforms with large or small epicardial patches. Fibrillation and defibrillation type were 
recorded usmg monophasic action potential electrodes. Normalized POS curve width, 
defined as (160.120)/150 (NCW), and ID probability at 150 were determined. Results: 
Each waveform/electrode combmation yielded a single point on the nonalized curve 
width YS %ID curve. Probability of ID at I50 ranged from almost 0% for MDS with small 
electrodes to 100% for BTE with large electrodes. Probability of ID at 150 closely corre- 
lated with normalized curve width (R2 = 0.97, figure). Conclusion: The finding that a 
high probability of immediate defibrillation in low regions of the POS curve correlates with 
narrow defibrillation POS curves may lead to improved waveform/ electrode combina- 
tions that will enhance defibrillation success. 
POSTER SESSION 
1074 Outcomes in Coronary Bypass Surgery 
Subsets 
Monday, March 31, 2003, 9:00 a.m.-l I:00 a.m. 
McCormick Place, Hall A 
Presentation Hour: 9:00 a.m.-10:OO a.m. 
1074-96 Platelet Glycoprotein Ilb/llla Antagonists Are Beneficial 
in Patients With Acute Coronary Syndromes Who 
Undergo In-Hospital Coronary Artery Bypass Surgery 
Marco Roffi David J. Mollterno, Michael S. Lauer, Joel Reginelli. Gang Jia, Eric J. Topol, 
The Cleveland Clinic Foundation, Cleveland, OH, Unwersity Hospital. Zurich, 
Switzerland 
Background:The use of platelet glycoprotein Ilb/lla receptor antagonists (GP Ilb/llla) in 
non-ST-segmenf elevation acute coronary syndromes (ACS) is widely accepted, espe- 
cially for percutaneous coronary intervention. However, their efficacy in patients under- 
going in-hospital coronary artery bypass grafting (CABG) is not well established. 
Methods: We performed a pooled analysis of 4 large-scale, placebo-controlled, Ilb/llla 
ACS trials, namely PURSUIT, GUSTO IV, PARAGON A, and PARAGON B. and 
addressed outcomes among patients undergoing in-hospital CABG (N=3166) according 
to treatment allocation. Results Reported in the table 
Conclusions: The use of GP Ilb/llla Inhibitors among patients with ACS undergoing in- 
hospital CABG I?. associated with a benefit that persists at 6 months. 
